Pharmaceuticals Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 745 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Industry Group Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals Mega (1.1tn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mega (624.3bn) -1–5 -$1M–$10M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (443.6bn) 0 No activity — 0–15%
Pharmaceuticals Mega (326.2bn) 0 No activity — —
Pharmaceuticals Mega (317.8bn) 0 No activity — 0–15%
Pharmaceuticals Mega (297.5bn) -1–5 -$1M–$10M -0–15% 0–15%
CH Novartis AG (NOVN)
Pharmaceuticals Mega (296.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Large (179.0bn) -1–5 -$100K–$1M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Large (164.0bn) 0 No activity — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (137.2bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals Large (115.3bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (105.4bn) 11–20 $100K–$1M 0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (102.5bn) 0 No activity — 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 No activity — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 No activity — —
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 No activity — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals Large (59.7bn) 1–5 < $100K 0–15% 15–50%
DE Bayer AG (BAYN)
Pharmaceuticals Large (55.1bn) 1–5 $1M–$10M 0–15% —
GB Haleon PLC (HLN)
Pharmaceuticals Large (41.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals Large (38.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (33.3bn) 0 No activity — 0–15%
Pharmaceuticals Large (32.0bn) 0 No activity — 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals Large (31.9bn) 1–5 $100K–$1M 0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals Large (29.8bn) 0 No activity — 0–15%
Pharmaceuticals Large (26.6bn) 0 No activity — 0–15%
Pharmaceuticals Large (19.1bn) 0 -$1M–$10M -0–15% 50%+
US Viatris Inc (VTRS)
Pharmaceuticals Large (18.3bn) 0 No activity — 0–15%
Pharmaceuticals Large (17.4bn) 0 No activity — 50%+
Pharmaceuticals Large (17.3bn) -6–10 -$1M–$10M -0–15% 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 No activity — 15–50%
Pharmaceuticals Large (15.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (15.3bn) 0 No activity — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals Large (15.0bn) 0 No activity — 50%+
Pharmaceuticals Large (13.5bn) 0 No activity — 50%+
Pharmaceuticals Large (12.9bn) 0 No activity — 50%+
Pharmaceuticals Large (12.7bn) 0 No activity — 15–50%
Pharmaceuticals Large (12.1bn) 0 No activity — 50%+
Pharmaceuticals Large (12.0bn) 1–5 $100K–$1M 0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 No activity — 0–15%
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (11.2bn) 0 No activity — 0–15%
Pharmaceuticals Large (10.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mid (9.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 No activity — 0–15%
Pharmaceuticals Mid (8.5bn) 0 $100K–$1M 0–15% 0–15%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals Mid (7.4bn) 0 No activity — 50%+
ES Grifols SA (GRF)
Pharmaceuticals Mid (7.1bn) 0 No activity — 15–50%
Pharmaceuticals Mid (7.1bn) 0 No activity — 50%+
Pharmaceuticals Mid (6.8bn) 0 No activity — 50%+
US Medicines Co (MDCO)
Pharmaceuticals Mid (6.8bn) 0 No activity — —
Pharmaceuticals Mid (6.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mid (5.7bn) -6–10 -$1M–$10M -0–15% 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals Mid (5.6bn) 0 No activity — 0–15%
Pharmaceuticals Mid (5.4bn) 0 No activity — 0–15%
Pharmaceuticals Mid (5.3bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals Mid (5.3bn) 0 No activity — 0–15%
Pharmaceuticals Mid (5.0bn) 0 No activity — 50%+
Pharmaceuticals Mid (4.8bn) 0 No activity — 15–50%
GB Indivior PLC (INDV)
Pharmaceuticals Mid (4.8bn) 0 No activity — 0–15%
Pharmaceuticals Mid (4.7bn) 0 No activity — 0–15%
Pharmaceuticals Mid (4.4bn) 0 No activity — 50%+
Pharmaceuticals Mid (4.4bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals Mid (4.3bn) 1–5 $100K–$1M 0–15% 15–50%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals Mid (4.2bn) -1–5 -$100M+ -0–15% 50%+
US Alkermes Inc (ALKS)
Pharmaceuticals Mid (4.1bn) 0 No activity — 0–15%
Pharmaceuticals Mid (4.1bn) -1–5 -< $100K -0–15% 15–50%
US Perrigo Co (PRGO)
Pharmaceuticals Mid (3.8bn) 0 No activity — 0–15%
Pharmaceuticals Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals Mid (3.6bn) 0 No activity — 15–50%
US Organon & Co (OGN)
Pharmaceuticals Mid (3.6bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals Mid (3.5bn) 0 No activity — 50%+
FR Virbac SA (VIRP)
Pharmaceuticals Mid (3.2bn) 0 No activity — 50%+
Pharmaceuticals Mid (3.2bn) 0 No activity — 0–15%
Pharmaceuticals Mid (3.2bn) 1–5 $10M–$100M 0–15% 50%+
Pharmaceuticals Mid (3.2bn) 0 No activity — 50%+
Pharmaceuticals Mid (2.9bn) 0 No activity — 0–15%
SE Camurus AB (CAMX)
Pharmaceuticals Mid (2.9bn) 0 No activity — 15–50%
ES Almirall SA (ALM)
Pharmaceuticals Mid (2.9bn) 0 No activity — 50%+
Pharmaceuticals Mid (2.9bn) 0 No activity — 15–50%
IN Laurus Labs Ltd (LAURUSLABS)
Pharmaceuticals Mid (2.8bn) 0 No activity — 15–50%
Pharmaceuticals Mid (2.8bn) 0 No activity — 0–15%
Pharmaceuticals Mid (2.7bn) 0 No activity — —
Pharmaceuticals Mid (2.5bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals Mid (2.5bn) 0 No activity — 15–50%
IN Pfizer Ltd (PFIZER)
Pharmaceuticals Mid (2.5bn) 0 No activity — 50%+
Pharmaceuticals Mid (2.5bn) -1–5 -$100K–$1M -0–15% 0–15%
US Vericel Corp (VCEL)
Pharmaceuticals Mid (2.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mid (2.3bn) 0 No activity — 15–50%
Pharmaceuticals Mid (2.2bn) 0 No activity — 0–15%
Pharmaceuticals Mid (2.2bn) 0 No activity — 0–15%
IN Natco Pharma Ltd (NATCOPHARM)
Pharmaceuticals Mid (2.2bn) 0 No activity — 50%+
BE Fagron NV (FAGR)
Pharmaceuticals Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals Mid (2.0bn) 0 No activity — 0–15%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Pharmaceuticals Mid (2.0bn) 0 No activity — 50%+
US Zai Lab Ltd (9688)
Pharmaceuticals Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals Small (1.7bn) -1–5 -$1M–$10M -0–15% 50%+